Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
LB1011 Cost and access changes with TNFa inhibitor biosimilars entering the market
HTML
PDF
Details
Locations
Year:
2024
Type:
conference-abstract
Source:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2024.06.1268
Authors:
J.V. Visingardi,
B. Sherwood
Institutions:
Albany Medical Center Hospital,
Dartmouth–Hitchcock Medical Center
Language:
English
Topic:
Biosimilars and Bioanalytical Methods
Subfield:
Immunology
Field:
Immunology and Microbiology
Domain:
Life Sciences
Keywords:
adalimumab,
TNF-alpha inhibitors,
biosimilars,
drug pricing,
patent expiry,
Medicare spending,
unit cost,
drug use trends
show all 8
SDG:
Good health and well-being
Open Access status:
bronze
OpenAlex ID:
W4400824466
Cites:
Cited by:
Related to:
10